Mieke De Wit

455 total citations
6 papers, 268 citations indexed

About

Mieke De Wit is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Mieke De Wit has authored 6 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Epidemiology, 2 papers in Hepatology and 1 paper in Infectious Diseases. Recurrent topics in Mieke De Wit's work include Hepatitis B Virus Studies (2 papers), Hepatitis C virus research (2 papers) and Barrier Structure and Function Studies (1 paper). Mieke De Wit is often cited by papers focused on Hepatitis B Virus Studies (2 papers), Hepatitis C virus research (2 papers) and Barrier Structure and Function Studies (1 paper). Mieke De Wit collaborates with scholars based in Belgium, United States and Netherlands. Mieke De Wit's co-authors include Inge Dierynck, Emmanuel Gustin, Sabine Hallenberger, Johan Vandersmissen, Kurt Hertogs, Willem Talloen, Chiara Cremolini, Michael Fried, Jeroen Aerssens and Kristina Vermeersch and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Journal of Virology.

In The Last Decade

Mieke De Wit

4 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mieke De Wit Belgium 3 111 101 97 87 49 6 268
Régine Rouzier‐Panis France 6 154 1.4× 77 0.8× 143 1.5× 84 1.0× 41 0.8× 10 339
I Jiménez‐Nácher Spain 7 79 0.7× 247 2.4× 122 1.3× 149 1.7× 30 0.6× 12 371
Kenneth E. Sherman United States 7 107 1.0× 92 0.9× 110 1.1× 42 0.5× 60 1.2× 9 331
Jan Maarten Vrolijk Netherlands 14 368 3.3× 74 0.7× 289 3.0× 24 0.3× 63 1.3× 21 488
Madeleine Willkom United States 7 40 0.4× 168 1.7× 75 0.8× 116 1.3× 57 1.2× 8 409
Paul Cernohous United States 9 26 0.2× 217 2.1× 23 0.2× 179 2.1× 76 1.6× 17 457
Alicia Sáez Spain 8 149 1.3× 51 0.5× 176 1.8× 53 0.6× 35 0.7× 10 329
Hugo Troonen Germany 10 199 1.8× 108 1.1× 108 1.1× 28 0.3× 75 1.5× 19 457
James Geib United States 10 57 0.5× 70 0.7× 71 0.7× 62 0.7× 100 2.0× 21 401
Tab Bonny United States 6 46 0.4× 251 2.5× 60 0.6× 227 2.6× 26 0.5× 6 358

Countries citing papers authored by Mieke De Wit

Since Specialization
Citations

This map shows the geographic impact of Mieke De Wit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieke De Wit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieke De Wit more than expected).

Fields of papers citing papers by Mieke De Wit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mieke De Wit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieke De Wit. The network helps show where Mieke De Wit may publish in the future.

Co-authorship network of co-authors of Mieke De Wit

This figure shows the co-authorship network connecting the top 25 collaborators of Mieke De Wit. A scholar is included among the top collaborators of Mieke De Wit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mieke De Wit. Mieke De Wit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Deman, Frederik, et al.. (2025). Claudin-18.2 expression in gastro-oesophageal adenocarcinoma in a Western population: Overlap with other biomarkers and prognostic value.. Journal of Clinical Oncology. 43(16_suppl). 4021–4021.
3.
Wit, Mieke De, et al.. (2013). Prevention and management of adverse events related to regorafenib. Supportive Care in Cancer. 22(3). 837–846. 52 indexed citations
4.
Darling, Jama M., Jeroen Aerssens, Gregory Fanning, et al.. (2010). Quantitation of pretreatment serum interferon-γ–inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology. 53(1). 14–22. 88 indexed citations
5.
Dierynck, Inge, Mieke De Wit, Emmanuel Gustin, et al.. (2007). Binding Kinetics of Darunavir to Human Immunodeficiency Virus Type 1 Protease Explain the Potent Antiviral Activity and High Genetic Barrier. Journal of Virology. 81(24). 13845–13851. 126 indexed citations
6.
Steen, Kristel Van, et al.. (2005). An equivalence test for comparing DNA sequences. Pharmaceutical Statistics. 4(3). 203–214. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026